Dr Gallow is our head researcher and head Doctor at Cannabis Oil Research. She has vast academic qualifications in both the medical sector, public health and strategic management. Dr Gallow is registered with the HPCSA in Clinical Pathology as a Medical Scientist. She is also a registered Professional Natural Scientist with the SACNASP. Additionally, Dr Gallow is registered as an Ethnomedicine Medical Practioner with EPASA and is also a registered Dr with the ANHA.
She holds a Masters Degree in Medical Science (MMedSci), a Masters in Public Health (MPH), Masters in Business Admin (MBA), and a PHD. She is currently completing a second PHD in the health profession. Furthermore, she completed her Clinical Pathology medical board exam Cum Laude (the most distinguished in the country of South Africa at the time). She has also completed a Medical Cannabis accredited course with the University of Washington, for Doctors. The Universities she obtained her degrees include, Durban University, University of Roehampton UK, Open University UK, University of Washington, UNISA and the MBA was affiliated with HARVARD University. To add to her educational profile Dr Gallow is also a qualified trainer and assessor with SETA and ETDP SAQA, as well as a Prince 2 Practioner registered with APMG.
Her successes started in Clinical Pathology as the Regional Manager of Ampath Drs Du Buisson & Partners. Here her role was to advise Clinicians on pathology results, interpretation and further diagnostic tests. She was responsible for the quality management and accreditation of the Ampath laboratories. She was then the Chief Operations Officer at Clinical Lab Services which is a division of the Wits University. Here, she was involved in many reputable clinical trials, such as the HIV vaccine study (IAVI), FACTS study, PreP study, IMPAACT, as well as the H3 Africa Biorepository study to name a few. She has been involved with and received funding from the NIH, USAID, PEPFAR, Bill and Melinda Gates Foundation for the clinical trial research projects. Dr Gallow has vast experience in ensuring a facility obtains and retains accreditation and certification and complies with required accreditation quality standards and legislation. She has been involved in ISO 17025 and 15189 standards, British Qualogy GCLP, FHI DAIDS, OHS Health and Safety, and FDA inspections.
Dr Gallow works closely with Trevor Parkinson and the rest of the senior team. Their combined expertise ensures only the best medical grade quality products and treatment of patients. Dr Gallow guides patients through their protocol and is able to assist with the weaning off of any unnecessary medication. Dr Gallow is also able to conduct pathology tests on all of the Cannabis Oil Research patients countrywide if required, and then monitor improvements on treatment. Lastly, Dr Gallow will be heading up training of all doctors and medical professionals on effective medical cannabis and treatments using a scientific perspective.